Antiplatelet therapy for atherothrombotic disease: an update for the primary care physician

Area of Science:

• Cardiovascular Medicine
• Vascular Biology
• Clinical Pharmacology

Background:

• Atherothrombosis is a widespread vascular disease leading to significant morbidity and mortality.
• Ischemic events like acute coronary syndromes and stroke are common, with high recurrence rates.
• Secondary prevention is crucial for managing patients with atherothrombosis.

Purpose of the Study:

• To review current treatment guidelines for secondary prevention of atherothrombosis.
• To highlight the role of pharmacotherapies, including antiplatelet agents, in managing atherothrombotic disease.
• To emphasize the importance of a continuum of care from acute to ambulatory settings.

Main Methods:

• Literature search of MEDLINE and PubMed for peer-reviewed publications and treatment guidelines.
• Focus on clinical trials of antiplatelet therapy in atherothrombotic disease (January 1996 - December 2006).
• Synthesis of guideline recommendations for secondary prevention strategies.

Main Results:

• Risk factor management and lifestyle modifications are foundational for prevention.
• Long-term pharmacotherapies, including antiplatelet agents, statins, and ACE inhibitors, are recommended.
• Physician awareness of guidelines is key for effective acute and long-term management.

Conclusions:

• Secondary prevention of atherothrombosis relies on guideline-adherent pharmacotherapy and risk factor control.
• A coordinated approach ensures comprehensive care for patients with atherothrombotic disease.
• Continued research and adherence to guidelines are vital for improving patient outcomes.